Barbara McGovern, MD

Vice President
Seres Therapeutics, Inc.
Cambridge, MA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 18 - New Antimicrobials and ID Diagnostics in the Pipeline - Bacterial

  Thursday, October 20, 2022
  8:00 AM – 9:00 AM US ET

• 50 - SER-109, an Oral Investigational Microbiome Therapy for the Prevention of Recurrent Clostridioides difficile Infection. Seres Therapeutics

  Thursday, October 20, 2022
  8:50 AM – 9:00 AM US ET